In the last trading session, 1.5 million Trevi Therapeutics Inc (NASDAQ:TRVI) shares changed hands as the company’s beta touched 0.48. With the company’s per share
Trevi Therapeutics Inc (NASDAQ:TRVI)’s traded shares stood at 0.77 million during the latest session, with the company’s beta value hitting 0.53. At the last check
Trevi Therapeutics Inc (NASDAQ:TRVI) has a beta value of 0.60 and has seen 8.67 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne